# ProcDNA

> ProcDNA is a self-funded analytics and technology consulting company serving life sciences organizations. It combines commercial strategy, patient and physician analytics, data engineering, AI, and managed services with proprietary products including Auxo for healthcare-professional intelligence and Nexora for enterprise data decision support.

- **Founded:** 2020
- **Headquarters:** South San Francisco, United States
- **Founders:** Ashish Agrawal (Founder & CEO), Harpreet Singh (Co-Founder)
- **Products:** Auxo, InsightO, Nexora, Commercial Planning & Insights, Technology & Managed Services
- **Notable:** Ranked No. 621 in the 2024 Inc. 5000, verified on Inc.’s company profile., Reported surpassing 200 employees in November 2024., Current homepage reports 33+ active clients, 10+ partnerships, and nine offices.

## Products & services

- **Auxo** — Proprietary HCP intelligence platform combining profiles, digital footprints, scientific activity, network mapping, opinion-leader identification, and engagement recommendations.
- **InsightO** — AI module within Auxo that prioritizes HCP signals and generates personalized written and audio briefings; documented in an August 2026 case study.
- **Nexora** — AI decision intelligence platform designed to monitor data, detect anomalies, explain business changes, and recommend actions alongside existing data and BI systems.
- **Commercial Planning & Insights** — Launch planning, forecasting, market access, segmentation, patient journeys, market research, and marketing mix analysis.
- **Technology & Managed Services** — CRM implementation, cloud infrastructure, commercial data integration, master data management, security, and ongoing IT support.
- **Data Science and GenAI** — Predictive modeling, patient-event prediction, next-best-action systems, research assistants, synthetic respondents, and workflow automation.
- **Sales Strategy & Operations** — Field-force planning, territory design, incentive compensation, and sales performance analytics.
- **Medical Affairs** — Scientific insights, HCP engagement support, medical intelligence, and analytics for medical teams.

## Achievements

- Ranked No. 621 in the 2024 Inc. 5000, verified on Inc.’s company profile.
- Reported surpassing 200 employees in November 2024.
- Current homepage reports 33+ active clients, 10+ partnerships, and nine offices.
- Opened a Bengaluru office on August 24, 2026.
- Company case study reports 40% of predicted alerts converting into therapy starts in one frontline Hodgkin’s lymphoma engagement; this is not an independently audited causal result.

## Latest updates

- **2026-08** — Announced a new Bengaluru office on August 24.
- **2026-08** — Published the InsightO case study describing written and voice-enabled HCP briefings within Auxo.
- **2026-09** — Published a frontline Hodgkin’s lymphoma case study reporting 40% predicted-alert conversion to therapy starts.
- **2026-09** — Published “Too Many Dashboards, Not Enough Truth,” addressing reporting definitions and governance.
- **2026-10** — Published medical affairs content on digital influence, conference intelligence and measuring impact, listed on its current homepage.

## Links

- Website: https://www.procdna.com/
- LinkedIn: https://www.linkedin.com/company/procdna/

---

Profile page: https://yespress.io/procdna
Published by YesPress — https://yespress.io
Last updated: 2026-10-24